ArticleFrontiers in immunology2025

CXCL12/CXCR4 axis governs Treg spatial dominance over CD8+ T cells via IL-2 sequestration: a dual therapeutic target in prostate cancer.

Junyi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.